Advances in Clinical and Experimental Medicine

Title abbreviation: Adv Clin Exp Med
JCR Impact Factor (IF) – 2.1 (5-Year IF – 2.0)
Journal Citation Indicator (JCI) (2023) – 0.4
Scopus CiteScore – 3.7 (CiteScore Tracker – 4.0)
Index Copernicus  – 171.00; MNiSW – 70 pts

ISSN 1899–5276 (print)
ISSN 2451-2680 (online)
Periodicity – monthly

Download original text (EN)

Advances in Clinical and Experimental Medicine

2018, vol. 27, nr 5, May, p. 695–701

doi: 10.17219/acem/68902

Publication type: original article

Language: English

Download citation:

  • BIBTEX (JabRef, Mendeley)
  • RIS (Papers, Reference Manager, RefWorks, Zotero)

Venous insufficiency: Differences in the content of trace elements. A preliminary report

Agnieszka Rusak1,B,C,D, Ewa Karuga-Kuźniewska2,A,E, Benita Wiatrak3,D,E, Maria Szymonowicz4,C,D, Mateusz Stolarski5,B, Małgorzata Radwan-Oczko6,B, Rafał J. Wiglusz7,C,D,E,F, Paweł Pohl8,A,C, Zbigniew Rybak4,D,E,F

1 Division of Histology and Embryology, Department of Human Morphology and Embryology, Wroclaw Medical University, Poland

2 Division of Infectious Diseases of Animals and Veterinary Administration, Department of Epizootiology and Clinic of Bird and Exotic Animals, Faculty of Veterinary Medicine, Wroclaw University of Environmental and Life Sciences, Poland

3 Department of Basic Medical Sciences, Wroclaw Medical University, Poland

4 Department of Experimental Surgery and Biomaterials Research, Wroclaw Medical University, Poland

5 Department of Trauma Surgery, Knappschaftskrankenhaus Bochum-Langendreer, University Hospital Bochum, Germany

6 Department of Periodontology, Wroclaw Medical University, Poland

7 Institute of Low Temperature and Structure Research, Polish Academy of Sciences, Wrocław, Poland

8 Division of Analytical Chemistry and Chemical Metallurgy, Faculty of Chemistry, Wroclaw University of Science and Technology, Poland

Abstract

Background. Venous insufficiency is still a serious clinical problem. The exact cause and molecular mechanisms of this disease are still unknown. In this study, we try to identify whether there is a difference in the level of trace elements between healthy and pathological veins. Our results show that insufficient veins have different levels of some trace elements: magnesium, calcium, manganese, and silicon compared to control samples. This study could lead to a better understanding of the molecular causes of venous insufficiency and may help to develop better methods of treatment.
Objectives. Nowadays, venous diseases are a very common clinical phenomenon. Venous insufficiency is thought to be one of the most common vein diseases. The exact mechanisms of its etiology are still unknown, although from a clinical point of view some risk factors include gender, age, changing hormone levels, heredity, and standing or sitting for long periods. An imbalance in trace elements could also play a crucial role in the development and/or progression of venous insufficiency.
Material and Methods. The trace element content in varicose vein walls and in normal vein walls was measured using an inductively coupled plasma-optical emission spectrometer (ICP-OES) after sample mineralization. Statistical analysis (the Mann-Whitney U test and the Friedman ANOVA) was performed to compare insufficient veins to controls (healthy veins).
Results. This study found statistically significant higher magnesium (Mg) ion levels in varicose veins compared to controls (p = 0.0067) and differences close to statistical significance in calcium (Ca), manganese (Mn), and silicon (Si) ion levels.
Conclusion. The results obtained could indicate oxidative stress occurring in chronic venous insufficiency as well as free radical neutralization pathways due to superoxide dismutase (SOD) activity with Mg, Mn and copper (Cu) ion involvement. Our results are consistent with literature data and are preliminary in nature.

Key words

trace elements, venous insufficiency, venous pathology

References (48)

  1. Raffetto JD, Khalil RA. Mechanisms of varicose vein formation: Valve dysfunction and wall dilation. Phlebology. 2008;23:85–98.
  2. Kucukguven A, Khalil RA. Matrix metalloproteinases as potential targets in the venous dilation associated with varicose veins. Curr Drug Targets. 2013;14:287–324.
  3. Simka M. Cellular and molecular mechanisms of venous leg ulcers development: The “puzzle” theory. Int Angiol. 2010;29:1–19.
  4. Raffetto JD, Qiao X, Koledova VV, Khalil RA. Prolonged increases in vein wall tension increase matrix metalloproteinases and decrease constriction in rat vena cava: Potential implications in varicose veins. J Vasc Surg. 2008;48:447–456.
  5. Zamboni P, Izzo M, Tognazzo S, et al. The overlapping of local iron overload and HFE mutation in venous leg ulcer pathogenesis. Free Radic Biol Med. 2006;40:1869–1873.
  6. Krzyściak W, Kowalska J, Kózka M, Papież MA, Kwiatek WM. Iron content (PIXE) in competent and incompetent veins is related to the vein wall morphology and tissue antioxidant enzymes. Bioelectrochemistry. 2012;87:114–123.
  7. Arredondo M, Núñez MT. Iron and copper metabolism. Mol Aspects Med. 2005;26:313–327.
  8. Simka M, Rybak Z. Hypothetical molecular mechanisms by which local iron overload facilitates the development of venous leg ulcers and multiple sclerosis lesions. Med Hypotheses. 2008;71:293–297.
  9. Skrzycki M, Czeczot H. The role of superoxide dismutase in the arising of tumors. Postępy Nauk Med. 2005;4:7–15.
  10. Xu B, Wu SW, Lu CW, et al. Oxidative stress involvement in manganese-induced alpha-synuclein oligomerization in organotypic brain slice cultures. Toxicology. 2013;305:71–78.
  11. Prasad AS, Beck FW, Bao B, et al. Zinc supplementation decreases incidence of infections in the elderly: Effect of zinc on generation of cytokines and oxidative stress. Am J Clin Nutr. 2007;85:837–844.
  12. Ojeda R, Aljama PA. Chronic microinflammation and endothelial damage in uremia. Nefrologia. 2008;28:583–586.
  13. Chiu JJ, Chien S. Effects of disturbed flow on vascular endothelium: Pathophysiological basis and clinical perspectives. Physiol Rev. 2011; 91:327–387.
  14. Karatepe O, Unal O, Ugurlucan M, et al. The impact of valvular oxidative stress on the development of venous stasis ulcer valvular oxidative stress and venous ulcers. Angiology. 2010;61:283–288.
  15. Krzyściak W, Kózka M, Kowalska J, Kwiatek WM. Role of Zn, Cu-trace elements and superoxide dismutase (SOD) in oxidative stress progression in chronic venous insufficiency (CVI). Przegląd Lek. 2010;67: 446–449.
  16. Plum LM, Rink L, Haase H. The essential toxin: Impact of zinc on human health. Int J Environ Res Public Health. 2010;7:1342–1365.
  17. Chasapis CT, Loutsidou AC, Spiliopoulou CA, Stefanidou ME. Zinc and human health: An update. Arch Toxicol. 2012;86:521–534.
  18. Leone N, Courbon D, Ducimetiere P, Zureik M. Zinc, copper, and magnesium and risks for all-cause, cancer, and cardiovascular mortality. Epidemiology. 2006;17:308–314.
  19. Tisato F, Marzano C, Porchia M, Pellei M, Santini C. Copper in diseases and treatments, and copper-based anticancer strategies. Med Res Rev. 2010;30:708–749.
  20. Saari JT, Schuschke DA. Cardiovascular effects of dietary copper deficiency. Biofactors. 1999;10:359–375.
  21. Gupta A, Lutsenko S. Human copper transporters: Mechanism, role in human diseases and therapeutic potential. Future Med Chem. 2009; 1:1125–1142.
  22. Cromwell GL. Copper as a nutrient for animals. In: Richardson HW, ed. Handbook of Copper Compounds and Applications. Boca Raton, FL: CRC Press; 1997.
  23. Tuschl K, Mills PB, Clayton PT. Manganese and the brain. Int Rev Neurobiol. 2013;110:277–312.
  24. Hirata Y. Manganese-induced apoptosis in PC12 cells. Neurotoxicol Teratol. 2002;24:639–653.
  25. Erikson KM, Aschner M. Manganese neurotoxicity and glutamate-GABA interaction. Neurochem Int. 2003,43:475–480.
  26. Tohno S, Tohno Y, Minami T, et al. A high accumulation of minerals in human internal jugular vein. Biol Trace Elem Res. 1998;62:17–23.
  27. Tohno S, Tohno Y, Masuda M, et al. A possible balance of magnesium accumulations among bone, cartilage, artery, and vein in single human individuals. Biol Trace Elem Res. 1999;70:233–241.
  28. Pilotelle-Bunner A, Cornelius F, Sebban P, Kuchel PW, Clarke RJ. Mechanism of Mg2+ binding in the Na+, K+-ATPase. Biophys J. 2009;96: 3753–3761.
  29. Rude RK, Singer FR, Gruber HE. Skeletal and hormonal effects of magnesium deficiency. J Am Coll Nutr. 2009;28:131–141.
  30. Nielsen FH, Milne DB, Klevay LM, Gallagher S, Johnson L. Dietary magnesium deficiency induces heart rhythm changes, impairs glucose tolerance, and decreases serum cholesterol in post menopausal women. J Am Coll Nutr. 2007;26:121–132.
  31. Kolte D, Vijayaraghavan K, Khera S, Sica DA, Frishman WH. Role of magnesium in cardiovascular diseases. Cardiol Rev. 2014;22:182–192.
  32. Ross AC, Taylor CL, Yaktine AL, Del Valle HB. Dietary Reference Intakes for Calcium and Vitamin D. Washington, DC: National Academies Press; 2011.
  33. Yáñez M, Gil-Longo J, Campos-Toimil M. Calcium binding proteins. Adv Exp Med Biol. 2012;740:461–482.
  34. Brini M, Ottolini D, Calì T, Carafoli E. Calcium in health and disease. Met Ions Life Sci. 2013;13:81–137.
  35. Pruksa S, Siripinyanond A, Powell JJ, Jugdaohsingh R. Silicon balance in human volunteers: A pilot study to establish the variance in silicon excretion versus intake. Nutr Metab (Lond). 2014;11(1):4. doi: 10.1186/1743-7075-11-4
  36. Martin KR. Silicon: The health benefits of a metalloid. Met Ions Life Sci. 2013;13:451–473.
  37. Jugdaohsingh R, Watson AIE, Pedro LD, Powell JJ. The decrease in silicon concentration of the connective tissues with age in rats is a marker of connective tissue turnover. Bone. 2015;75:40–48.
  38. Gropper S, Smith J. Nonessential Trace and Ultratrace Elements. Advanced Nutrition and Human Metabolism. 6th ed. Belmont, CA: Wadsworth; 2013.
  39. Mertz W, ed. Trace Elements in Human and Animal Nutrition. Volume 2. 5th ed. Orlando, FL: Academic Press; 2012.
  40. Nakashima Y, Kuroiwa A, Nakamura M. Silicon contents in normal, fatty streaks and atheroma of human aortic intima: Its relationship with glycosaminoglycans. Br J Exp Pathol. 1985;66:123–127.
  41. Garcimartín A, Merino JJ, Santos-López JA, et al. Silicon as neuroprotector or neurotoxic in the human neuroblastoma SH-SY5Y cell line. Chemosphere. 2015;135:217–224.
  42. Tohno S, Tohno Y, Moriwake Y, Azuma C, Ohnishi Y, Minami T. Quantitative changes of calcium, phosphorus, and magnesium in common iliac arteries with aging. Biol Trace Elem Res. 2001;84:57–66.
  43. Myers HL. Topical chelation therapy for varicose pigmentation. Angiology. 1966;17:66–68.
  44. Moosavi K, Vatankhah S, Salimi J, Moradi M. A proton induced X-ray emission (PIXE) analysis of concentration of trace elements in varicose veins. Int J Radiat Res. 2010;8:117–121.
  45. Aubail A, Méndez-Fernandez P, Bustamante P, et al. Use of skin and blubber tissues of small cetaceans to assess the trace element content of internal organs. Mar Pollut Bull. 2013;76:158–169.
  46. Heidari B, Riyahi Bakhtiari A, Shirneshan G. Concentrations of Cd, Cu, Pb and Zn in soft tissue of oyster (Saccostrea cucullata) collected from the Lengeh Port coast, Persian Gulf, Iran: A comparison with the permissible limits for public health. Food Chem. 2013;141:3014–3019.
  47. Döker S, Hazar M, Uslu M, Okan İ, Kafkas E, Boşgelmez İİ. Influence of training frequency on serum concentrations of some essential trace elements and electrolytes in male swimmers. Biol Trace Elem Res. 2014;158:15–21.
  48. Krebs N, Langkammer C, Goessler W, et al. Assessment of trace elements in human brain using inductively coupled plasma mass spectrometry. J Trace Elem Med Biol. 2014;28:1–7.